[Licensing negotiation in progress]
[Invitation for Expression of Interest- Deadline: 17 September 2020]
We are inviting expressions of interest (EoI) for commercializing “Prism Vote” technology. The innovation is developed by Professor Wang Haitian Maggie, Professor of the Jockey Club School of Public Health and Primary Care of The Chinese University of Hong Kong (CUHK Reference: 19/MED/902).
The Technology
The Prism Vote method performs individualized disease risk prediction by decomposing a subject’s disease risk into multiple liability layers for the disease and integrating the total risk through the Bayesian probability framework. The disease liability layers could be recognized by but not restricted to analyzing genetic architecture of the genome data. The method enables personalized risk estimation as each person acquires a unique spectrum of disease liabilities. The Prism Vote process can be applied to various complex disorders prediction problem based on genome or omics datasets.
Commercialization The technology is now available for licensing on an exclusive basis. In order to fully realize the benefit of the technology, we expect substantial investment is necessary to enable further research and development. In addition to the financial commitment, the licensee is expected to have the appropriate expertise as well as plans in marketing and strategizing the end product to ensure successful transfer of the technology to the society. Previous or existing business involvement and experience in this area is a plus.
This invitation of expression of interest is without prejudice. We also stress that this invitation is not a tender, and the University is not bound to accept any offer, or to accept the highest monetary offer, as there are additional considerations (such as the widest possible benefit to the community) that we, as a public institution, will need to take into consideration.